Myriad Genetics has been in business for almost 30 years and we are a global leader in precision medicine.  Click on the image below to download our midyear FY2020 fact sheet.

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.